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Introduction
Peritonitis, a common complication of peritoneal dialysis (PD), contributes to treatment failure, hospitalization and mortality rate. Therefore, early diagnosis and easily obtainable predictors of adverse outcomes are extremely critical. It is well-known that the diagnosis of peritonitis is based on symptoms, peritoneal effluent cell count and micro-organisms culture. The high values of effluent white cell on the third day or prolonged elevation of PD fluid white cell count are identified as risk factors of adverse outcome [1] [2] [3] . Some causative organisms are also correlated to treatment failure of peritonitis, such as enteric organisms, gram-negative organisms and fungi [4] . However, neither PD fluid white cell count on the third day nor the presence of causative organisms is available at the initiation of peritonitis. By comparison, symptoms including abdominal pain, fever and cloudy fluid were usually reported by patients and thus easily available at onset.
Disease severity scores (DSS) are calculated as the sum of points for pain and fever, as explained below (Table 1) . Since this clinical scoring system can reflect the severity of clinical symptoms through a simple and convenient scale, it has been applied broadly in the paediatric PD community [5] [6] [7] after being introduced by Schaefer et al. [8] in 1999. For paediatric PD patients, the severity of the presentation of abdominal pain and fever varies and is somewhat organism specific, which could be considered as a clinical clue for estimating the causative organism and prescribing the empiric antibacterial medications [9] . Meanwhile, the association of DSS and the outcome of peritonitis is controversial in the field of paediatric PD. Based on the International Paediatric Peritonitis Registry (IPPR) data, Scott et al. indicated that there was no association between DSS on Day 0 and relapse in 20 episodes of enterococcal peritonitis [7] , but Zurowska et al. reported that the likelihood of catheter removal was greatest in the presence of high DSS at presentation in gram-negative peritonitis [4] . Lane et al. [6] reported that DSS could not predict the relapse peritonitis. Compared to data from paediatric PD patients, the information on the association between DSS, causative organisms and outcome of peritonitis is lacking in adult PD patients.
We aimed to address this issue in patients presenting with an incident episode of peritonitis through a singlecentre cohort. Specifically, our objectives were to determine if DSS at the time of diagnosis is associated with dialysate white cell counts and the severity of causative organism, and if DSS could predict an increased risk of adverse outcomes in PD-associated peritonitis, including the switch to haemodialysis and peritonitis-related death.
Materials and methods

Subjects
This prospective cohort study was carried out at the PD centre of Peking University First Hospital. All consecutive PD patients who presented with PD-associated peritonitis between 1 January 2008 and 31 December 2010 were recruited. All patients were inserted with Tenckhoff catheters and dialysed with lactate-buffered glucose dialysate and twin-bag connection system (Baxter Healthcare, Guangzhou, China). Prophylactic cefazolin was administered prior to Tenckhoff catheter placement in the majority of cases. Patients and their caregivers were trained by nurses in the dialysis clinic with a standard initial training program before they could do the exchange by themselves, which has been published in our previous paper [10] . The study was approved by the Medical Ethical Committee of Peking University. Written informed consent was obtained from each patient.
Diagnosis of peritonitis
All patients in our centre were asked to contact us as soon as possible via an emergency call if they experienced cloudy effluent or digestive tract symptoms of unknown origin. Each patient had to be assessed by a PD nurse and a physician. Peritonitis was defined as the presence of at least two of the following conditions: (i) abdominal pain or tenderness, (ii) presence of white blood cells (!100 cells/mL) in peritoneal effluent, with at least 50% polymorphs and (iii) positive dialysate culture results [11] . In cases where abdominal pain or tenderness was unavailable, cloudy fluid combined with at least one of the latter two conditions were considered diagnostic.
The DSS, as shown in Table 1 , was calculated as the sum of points for pain (0-no pain; 1-moderate pain or nausea not requiring a specific therapy; 2-severe pain, usually requiring analgesic therapy or vomiting and 3-peritoneal pain with tense abdomen and/or paralytic bowel) and fever (0 indicates <37.5°C, 1 indicates 37.5-38.9°C and 2 indicates >38.9°C). The final scores ranged from 0 to 5.
Basic demographic and laboratory data
Each episode of peritonitis was recorded in a separate database, including the patient's age, gender, presence of diabetes at the time of peritonitis, duration of PD before the onset of the peritonitis and the latest biochemical parameters measured within 3 months before the onset of the peritonitis (such as serum albumin, haemoglobin, urea nitrogen and creatinine). The biochemical profile including haemoglobin and serum albumin was examined using an automatic Hitachi chemistry analyser.
Patients were instructed to bring the first cloudy fluid to the dialysis centre immediately once peritonitis was suspected. The examination of PD fluid included cell count, causative micro-organisms and drug sensitivity. Two aliquots of PD effluent were sent to perform cell count (5 mL into tubes) and bacterial culture (10 mL into blood culture bottle) using the BACTAC Blood System (BD Biosciences, Franklin Lakes, NJ). For each episode of peritonitis, we recorded the initial peritoneal dialysate white blood cell count and then the serial white blood cell counts on scheduled follow-up visits.
Treatment and follow-up
Peritonitis episodes were treated with the standard antibiotic protocol of our centre, modified from the ISPD guidelines [11, 12] . In general, initial antimicrobial therapy for peritonitis consisted of intra-peritoneal administration of a third generation Cephalosporin plus Cefazolin (both with a single dose of 1 g once daily). Antibiotic treatment was modified once the culture results and antimicrobial sensitivities became available. If peritonitis was completely resolved during the first 5 days, the standard duration of antibiotic treatment was 2 weeks for staphylococcus epidermidis infection and culture-negative peritonitis and 3 weeks for other types of bacteria and polymicrobial infection. Routine follow-up visits were scheduled on Days 1, 3, 5, 7, 14 and 21 following initiation of treatment. Patients were switched to haemodialysis and their PD catheters were subsequently removed if they represented a lack of improvement after 7-14 days of appropriate antibiotic therapy, if PD dialysate grew yeast species or tuberculosis at any time and if a clinical tunnel infection was diagnosed at the start as suggested by the ISPD guidelines [11] . The total scores are calculated as the sum of scores for fever and abdominal pain.
Our goal was prediction of treatment outcome (dichotomized as success and failure) in PD-related peritonitis. Treatment success was defined as complete resolution of peritonitis (PD fluid white blood cells <100 cells/ mL, and patients experienced a clinical resolution) without the need for Tenckhoff catheter removal. Conversely, treatment failure included death and switch to haemodialysis during the course of peritonitis treatment [13] . Death related to peritonitis was defined as death of a patient with active peritonitis or within 2 weeks of a peritonitis episode [12] .
Statistical analyses
Statistical analysis was performed by SPSS for Windows software version 13.0 (SPSS Inc, Chicago, IL). Continuous data that are normally distributed are referred to as parametric data and data that are not normally distributed as non-parametric data. Parametric data are presented as mean AE standard deviation. Non-parametric data are presented as median values with their interval from the 25th to 75th percentile. Categorical variables were expressed as a percentage or ratio. Patients' data were compared by using the chi-square test for categorical variables and by using the Kruskcal-Wallis H test for continuous variables. To analyse the time course of dialysate white cell counts with respect to the baseline DSS counts, we used the generalized linear mixed model for repeated measures. The generalized linear mixed model method was applied to take into account the correlation between repeated measurements within the same patient. The multivariate model contained dialysate white cell counts as a dependent variable and categories of DSS as an independent variable, adjusted for age and gender. Multiple logistic regression model were used to determine the association between baseline DSS and treatment failure, which were adjusted for age, gender, diabetes, dialysis duration, causative organism (Group 1: culture-negative infections and non-Staphylococcus aureus gram-positive infections; Group 2: S. aureus, gram-negative and polymicrobial infections) and the median of white blood cells count in PD fluid on third day. To test the impact of episodes without organism cultures, we built another multiple logistic regression model to explore the association between DSS counts and treatment failure in all 219 cases and 204 episodes with organism cultures, which were adjusted for age, gender, diabetes, dialysis duration and the median of dialysate white cell counts on third day. Odds ratios (ORs) and 95% confidence intervals (CI) were calculated. All probabilities were two tailed, and the level of significance was set at 0.05.
Results
The characteristics of peritonitis
There were 380 patients receiving PD therapy in our unit between January 2008 and December 2010. A total of 219 episodes of peritonitis in 146 PD patients were collected. The peritonitis rate was 62 patient-months during this study period. Fifty-eight participants (39.7%) were male and 61 (41.8%) had diabetes, the mean age was 60.6 AE 12.9 years. The median time of peritonitis episodes since the beginning of PD was 34.9 (17.8-56.0) months. The baseline data showed 34.2 AE 5.74 g/L of serum albumin and 10.6 AE 1.87 of haemoglobin before the occurrence of peritonitis. There were 171 of 219 (78.1%) episodes leading to treatment success. Of the remaining 48 (21.9%) episodes with treatment failure, 23 episodes resulted in death and 25 episodes led to the transfer to haemodialysis and required Tenckhoff catheter removal. Unresolved peritonitis was the only cause for the transfer to haemodialysis and no case of temporary ultrafiltration failure. The prevalence of treatment failure including death and transfer to haemodialysis according to DSS group are shown in Table 3 .
Among 219 episodes of peritonitis, 204 of 219 (93.2%) episodes were examined with organism cultures before antibiotics were used. The mean age, dialysis duration, distribution of gender and diabetes, DSS counts, dialyate white cell counts on Days 1, 3, 5 and 7 were not different between episodes with and without organism cultures (P > 0.05). Among 204 episodes with organism cultures, a total of 89 (43.6%) episodes were due to gram-positive organisms, 40 (19.6%) gram-negative organisms, 13 (6.4%) polymicrobial, 5 (2.5%) fungi, 1 (0.5%) tuberculosis and 56 (27.5%) culture-negative organisms. The detailed categories of organisms are shown in Table 2 .
The DSS, clinical characteristics, dialysate white cell count and causative organisms
The median of DSS at baseline was 1 (1) (2) Table 3 . The patients with lower counts of DSS in Groups 1-3 had a shorter duration on dialysis therapy compared to patients with the highest counts of DSS in Group 4 (P < 0.01-0.05). By using the general linear mixed model, the difference in the trend of dialysate white cell counts between groups during the follow-up was statistically significant, as shown in Figure 1 , with 0.001 of P-values. The higher DSS counts at the baseline, higher dialysate white cell counts were found on the first and third day (P ¼ 0.003, 0.001, respectively). The dialysate white cell counts on the first and third day were significantly lower in Groups 1 and 2 compared to those in Group 4 (P < 0.01 to 0.05). The number and percentage of causative organisms examined to all the episodes at onset. b The number and percentage of specific organism to total causative organisms examined.
However, there were no significant differences in dialysate white cell counts on the fifth and seventh day between groups (P > 0.05). With respect to the categories of causative organisms, the percentage of culture-negative organisms in Group 1 was significantly higher than that in Group 4 (P < 0.01), but no significant differences of percentages of gram positive, gram negative, polymicrobial, fungi and tuberculosis observed between groups (P > 0.05). The percentage of S. aureus, gram negative and polymicrobial organisms was not different between groups either (P ¼ 0.17). The mean age in Group 1 was numerically different from other groups but did not achieve a statistical difference (P ¼ 0.07). The distribution of gender and diabetes were not significantly different between groups (P > 0.05).
The predicting role of DSS in the outcomes of peritonitis
Multiple logistic regressions were performed to examine the association between DSS counts and outcomes of peritonitis episodes with models constructed from variables identified previously. As shown in Table 4 , DSS could not predict the treatment failure after adjusting for age, gender, diabetes, dialysis duration, dialysate white cell count on the third day, the presence of S. aureus, gramnegative organisms and polymicrobial organisms. When 0 score of DSS as referenced, the adjusted OR of 1, 2 and 3 scores were 0.51 (0.15-1.71), 0.26 (0.06-1.08) and 1.34 (0.32-5.59), respectively. More than 280 cells/mm 3 (median) of dialysate white cell count on third day was independently significant risk factor for the treatment failure with adjusted OR of 3.09 (1.14-8.39) (P ¼ 0.03). Although the presence of S. aureus, gram-negative and polymicrobial organisms was associated with an increased risk for treatment failure with 2.74 (1.27-5.91) of OR (P ¼ 0.01) in the univariate regression model, it could not predict treatment failure in the multivariate regression model with adjusted OR of 1.99 (0.76-5.27) (P ¼ 0.16). To test the impact of episodes without organism cultures on outcome, we further analysed the association between DSS counts and peritonitis outcome in multiple regression model containing age, gender, diabetes, dialysis duration, dialysate white cell count on the third day as covariates in all 219 episodes and only 204 episodes with organism cultures, respectively. Again, DSS counts did not predict the treatment failure including death and transfer to haemodialysis. The dialysate white cell counts >280 cells/mm3 was still a significant predictor for treatment failure with adjusted OR of 3.80 (1.58-9.15) in all The number and percentage of causative organisms examined to all the episodes at onset. b The number and percentage of specific organism to total causative organisms examined. *P < 0.05, **P < 0.01, ***P < 0.001 compared to the group of DSS !3. 
Discussion
In our prospective study with a total of 219 peritonitis episodes recorded over 2 years, 21.9% of episodes resulted in treatment failure including peritonitis-related death and transfer to haemodialysis. Despite previous studies in the paediatric PD population, which showed the association of higher DSS at baseline, severe causative organisms and worse outcome [4] , this link was not observed in this adult cohort. As shown in our data, the DSS at baseline did not correlate to the dialysate white cell counts on the fifth and seventh day and the severity of causative organisms. It is thus not possible to identify the likely worst case of peritonitis from easily available symptoms at onset in our cohort. The present data supports one 10-year-old study showing no association between fever or abdominal pain and outcome of peritonitis in adult PD patients [1] . In terms of evaluating the severity of symptoms at the occurrence of peritonitis, the DSS is a simple and practical tool for clinicians. The calculation of DSS is based on the points for pain and fever, which are common symptoms for systemic infection. With regard to the associations of baseline characteristics and DSS, we did not observe differences in age, distribution of gender and presence of diabetes between groups according to the extent of DSS.
The association of DSS and dialysate white cell counts was observed on the first and third day, rather than on the fifth and seventh day. Chow et al. [3] indicated the superiority of dialysate white cell count on Day 3 to predict the outcome of peritonitis compared to that on Day 1. It is also reported by Krishnan et al. that the odds of treatment failure were significantly higher when peritoneal dialysate cell counts exceeded 100/mm 3 for >5 days [1] . The prolonged elevation of dialysate white cell counts in the late course of peritonitis actually reflects the poor treatment response to antibiotics and thus predicts the worse outcome. Our data further supports the above phenomenon. As shown in our data, the percentage of culture-negative organisms was significantly higher in patients with 0 of DSS, indicating that peritonitis originating from culture-negative organisms is relatively mild. However, there were no significant differences in the percentage of severe causative organisms including S. aureus, gram negative and polymicrobial and the general distribution of causative organisms between patients with varied degree of DSS. To our knowledge, this is the first adult study exploring the relationship between DSS and causative organisms. In the paediatric population, the DSS was examined at onset in most studies. As reported by Zurowska et al. [4] and Warady et al. [5] , initial manifestations of peritonitis were uniformly severe for gram-negative causative organisms, characterized by a high mean of DSS. By comparison, the severity is generally mild-moderate with peritonitis secondary to culturenegative organisms and coagulase-negative Staphylococcus [9] . Most recently, one study conducted in a paediatric population reported similar results to us [7] , which did not observe the differences in DSS between S. aureus, enterococcal, gram-negative and other gram-positive organisms groups. We are aware that the clinical clues concluded from paediatric PD patients are not necessarily applicable to adult PD patients. Unfortunately, in the adult population, although the clinical characteristics, response to therapy and outcome of peritonitis originated from some specific organism such as enterobacteriaceae [14] , coagulase-negative staphylococcal [15] , multibacterial [16] and culture negative [17] were described in detail, the data of severity of symptoms was not collected at the initiation of peritonitis in the majority of studies. Future observational studies in the adult PD population should include this information to determine whether the type of causative organism can be estimated from clinical symptoms at onset.
Our data showed that 27.5% of episodes were due to culture-negative organisms despite that the method for organisms culture applied in this study followed the recommendation of culture techniques by ISPD [12] . That percentage is similar to those reported by others from IPPR data recently, 31% in the study of Warady et al. [5] and study of Scott et al. [7] . However, it is necessary to evaluate the culture methods in our lab with >20% of culture-negative episodes, since 10.9 to 21% of culture-negative peritonitis episodes were reported by previous studies [1, 3, [18] [19] [20] . In addition, patients with 0 count of DSS had the highest percentage of culture-negative organisms. The characteristics of culture-negative peritonitis was similar to the reports of Warady et al. [5] , which indicated that culture-negative peritonitis was associated with a significantly lower DSS than episodes caused by other organisms.
To the best of our knowledge, our report, which represents a large cohort of adult PD patients, is the first to provide DSS value at onset. The number of outcome events were 48, achieving 21.9% of total episodes, which allowed us to build a regression model containing DSS and a few recognized confounders to explore the predicting role of DSS. Its prospective design and rigorous follow-up are also strengths. The demographic characteristics and the distribution of causative organisms are typical of those previously reported, showing the generalizability of our findings to other PD cohorts elsewhere. The single-centre design of this study provided more complete and accurate information compared to studies from registry data. At last, the predefined antibiotic protocol was applied to all the peritonitis episodes, which precluded a selection bias on clinical outcome due to different antibiotic therapies.
Our study also has a couple of limitations. First of all, detailed information of DSS could not be acquired, such as the extent of fever and pain and serial measurements of DSS during the follow-up. That would preclude us from exploring the potential mechanisms for the observed phenomena. Secondly,~7% of episodes were not examined with organism cultures before the usage of antibiotics since some patients lived far away from us and were unwilling to send the samples or some patients lacked knowledge about sample collection. However, the distribution of demographic and basic clinical data is similar between episodes with and without organism data. The relationship between DSS and peritonitis outcome was not changed despite that episodes lacking organism data were excluded. Therefore, we assumed that the distribution of organisms among these missing samples was consistent among the whole cohort. The association between DSS and outcomes might be not influenced accordingly. Finally, although DSS is now shown to be correlated to peritonitis outcomes, we could not preclude that this negative finding is due to a relatively small sample size of our study. To date, the negative or positive associations between DSS and peritonitis outcome have been explored in 10-490 episodes in paediatric patients [4, 6, 7] . We also need more observational studies performed in adult peritonitis cohort to determine the correlation of DSS and outcome.
In summary, our study did not observe that DSS at onset of peritonitis episodes was associated with the prolonged elevation of dialysate white cell counts, severity of causative organisms and the outcome of peritonitis episodes in adult PD patients. Thus, it is not possible to identify likely cases of peritonitis tending to drop out at presentation in our adult PD cohort. Clinicians should continue to rely on effluent cell count and organism cultures to make this diagnosis during the occurrence of peritonitis.
